Openbookopenbook
Equity
PHR
+0.0 · +0.00%
USD · NYSE

Phreesia Inc(PHR) Stock Analysis | Healthcare

USD --+0.00%
Reward67High
Risk47Moderate
75%Data
Thin 2% profit margin · Revenue growing 13% YoY
Growth Machine
Market Cap:750.56M
ⓘ
Reward Rating
67
High
Reward Assessment
75% data coverage
Top 25% of stocksView factors
ⓘ
Risk Rating
47
Moderate
Risk Assessment
3 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on PHR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for PHR, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $13.94.

What is Phreesia Inc?

provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

PHR · Verdict

Solid reward · moderate risk

PHR scores well on growth and valuation with no major weaknesses flagged in the model.

Based on 88% data coverage

PHR · Verdict

What’s working & what to watch

Strengths 3

  • Growth80/100

    Revenue +19.6% CAGR

  • Valuation77/100

    P/E 15.8× · PEG 0.54

  • Cash flow69/100

    14% free-cash-flow margin

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Phreesia Inc?

provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 750.56M, and a P/E ratio of 75.9x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (67)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Health Information Services names that are close enough in size to make side-by-side comparison useful.

RSLBFSmall Cap / 836M market cap
RaySearch Laboratories AB (publ)
Compare
HSTMSmall Cap / 844M market cap
HealthStream Inc
Compare
TALKSmall Cap / 871M market cap
Talkspace Inc
Compare
Company Information
SectorHealthcare
IndustryHealth Information Services
Market Cap750.56M
P/E Ratio75.9375
Dividend YieldN/A
Beta0.844
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
850,493 shares
$462k
0
6-9months
1129,890 shares
$489k
0
9-12months
0
0
1 disclosure without share count
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.